Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2304372-79-8
2. (1r,3r)-3-[(7s)-2-[(r)-(5-fluoro-2-methoxyphenyl)-hydroxymethyl]-6-methoxycarbonyl-7-methyl-8,9-dihydro-7h-imidazo[4,5-f]quinolin-3-yl]cyclohexane-1-carboxylic Acid
3. Pocenbrodib [inn]
4. Pocenbrodib (usan/inn)
5. Ei2n46w53z
6. Chembl5314476
7. Schembl20818742
8. Bdbm645365
9. Glxc-27898
10. Us20240016795, Compound 1
11. Da-76966
12. Hy-141546
13. Cs-0180919
14. D12924
15. (1r,3r)-3-((s)-2-((r)-(5-fluoro-2-methoxyphenyl)(hydroxy)methyl)-6-(methoxycarbonyl)-7-methyl-6,7,8,9-tetrahydro-3h-imidazo[4,5-f]quinolin-3-yl)cyclohexanecarboxylic Acid
16. (1r,3r)-3-{(7s)-2-[(r)-(5-fluoro-2- Methoxyphenyl)(hydroxy)methyl]-6-(methoxycarbonyl)- 7-methyl-6,7,8,9-tetrahydro-3h-imidazo[4,5-f]quinolin- 3-yl}cyclohexane-1-carboxylic Acid
17. 6-methyl (7s)-3-[(1r,3r)-3-carboxycyclohexyl]-2-[(r)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-6h-imidazo[4,5-f]quinoline-6-carboxylate
18. 6h-imidazo[4,5-f]quinoline-6-carboxylic Acid, 3-[(1r,3r)-3-carboxycyclohexyl]-2-[(r)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl Ester, (7s)-
19. Synthesis Of (1r,3r)-3-[(7s)-2-[(r)-(5-fluoro-2-methoxyphenyl)(hydroxy)methyl]-6-(methoxycarbonyl)-7-methyl-3h,6h,7h,8h,9h-imidazo[4,5-f]quinolin-3-yl]cyclohexane-1-carboxylic Acid
| Molecular Weight | 525.6 g/mol |
|---|---|
| Molecular Formula | C28H32FN3O6 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 114 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 864 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
94
PharmaCompass offers a list of Pocenbrodib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pocenbrodib manufacturer or Pocenbrodib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pocenbrodib manufacturer or Pocenbrodib supplier.
PharmaCompass also assists you with knowing the Pocenbrodib API Price utilized in the formulation of products. Pocenbrodib API Price is not always fixed or binding as the Pocenbrodib Price is obtained through a variety of data sources. The Pocenbrodib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pocenbrodib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pocenbrodib, including repackagers and relabelers. The FDA regulates Pocenbrodib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pocenbrodib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pocenbrodib supplier is an individual or a company that provides Pocenbrodib active pharmaceutical ingredient (API) or Pocenbrodib finished formulations upon request. The Pocenbrodib suppliers may include Pocenbrodib API manufacturers, exporters, distributors and traders.
Pocenbrodib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pocenbrodib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pocenbrodib GMP manufacturer or Pocenbrodib GMP API supplier for your needs.
A Pocenbrodib CoA (Certificate of Analysis) is a formal document that attests to Pocenbrodib's compliance with Pocenbrodib specifications and serves as a tool for batch-level quality control.
Pocenbrodib CoA mostly includes findings from lab analyses of a specific batch. For each Pocenbrodib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pocenbrodib may be tested according to a variety of international standards, such as European Pharmacopoeia (Pocenbrodib EP), Pocenbrodib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pocenbrodib USP).
